标题
Gene therapy clinical trials, where do we go? An overview
作者
关键词
-
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 153, Issue -, Pages 113324
出版商
Elsevier BV
发表日期
2022-06-30
DOI
10.1016/j.biopha.2022.113324
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation
- (2022) Valentín Ortiz-Maldonado et al. Frontiers in Oncology
- siRNA drug Leqvio (inclisiran) to lower cholesterol
- (2022) Julia M. Migliorati et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Lumasiran: First Approval
- (2021) Lesley J. Scott et al. DRUGS
- BNT162b2 mRNA COVID-19 Vaccine: First Approval
- (2021) Yvette N. Lamb DRUGS
- Recent advances in regenerative medicine strategies for cancer treatment
- (2021) Vahid Mansouri et al. BIOMEDICINE & PHARMACOTHERAPY
- How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?
- (2021) Myriam Sainz-Ramos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
- (2021) Julian D. Gillmore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives
- (2021) Roman P. Labbé et al. Viruses-Basel
- Golodirsen: First Approval
- (2020) Young-A Heo DRUGS
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
- (2020) Jian Gao et al. Cancers
- CAR-T design: Elements and their synergistic function
- (2020) Jayapriya Jayaraman et al. EBioMedicine
- CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
- (2020) Fathema Uddin et al. Frontiers in Oncology
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
- (2020) Haydar Frangoul et al. NEW ENGLAND JOURNAL OF MEDICINE
- The once and future gene therapy
- (2020) Karen Bulaklak et al. Nature Communications
- DC-Based Vaccines for Cancer Immunotherapy
- (2020) Chunmei Fu et al. Vaccines
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Gene Therapy Leaves a Vicious Cycle
- (2019) Reena Goswami et al. Frontiers in Oncology
- Onasemnogene Abeparvovec: First Global Approval
- (2019) Sheridan M. Hoy DRUGS
- Volanesorsen: First Global Approval
- (2019) Julia Paik et al. DRUGS
- Advances and challenges for hemophilia gene therapy
- (2019) Paul Batty et al. HUMAN MOLECULAR GENETICS
- Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
- (2019) Alireza Shahryari et al. Frontiers in Genetics
- The approved gene therapy drugs worldwide: from 1998 to 2019
- (2019) Cui-Cui Ma et al. BIOTECHNOLOGY ADVANCES
- State‐of‐the‐art human adenovirus vectorology for therapeutic approaches
- (2019) Jian Gao et al. FEBS LETTERS
- Translating anti-CD19 CAR T-Cell therapy into clinical practice for relapsed/refractory diffuse large B-Cell lymphoma
- (2018) Victor A. Chow et al. BLOOD
- Oncorine, the World First Oncolytic Virus Medicine and its Update in China
- (2018) Min Liang CURRENT CANCER DRUG TARGETS
- Development of Gene Therapeutics for Head and Neck Cancer in China: From Bench to Bedside
- (2018) Wei Guo et al. HUMAN GENE THERAPY
- The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
- (2018) Wei-Wei Zhang et al. HUMAN GENE THERAPY
- Gene therapy clinical trials worldwide to 2017: An update
- (2018) Samantha L. Ginn et al. JOURNAL OF GENE MEDICINE
- Arthritis Gene Therapy Approved in Korea
- (2018) Christopher H. Evans et al. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
- Arthritis gene therapy is becoming a reality
- (2018) Christopher H. Evans et al. Nature Reviews Rheumatology
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID
- (2018) Heide Stirnadel-Farrant et al. Orphanet Journal of Rare Diseases
- Talimogene laherparepvec: First in class oncolytic virotherapy
- (2018) Robert M. Conry et al. Human Vaccines & Immunotherapeutics
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- (2018) Mathew S. Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Teaching an old dog new tricks: next-generation CAR T cells
- (2018) Nicholas Tokarew et al. BRITISH JOURNAL OF CANCER
- A new era in the management of Duchenne muscular dystrophy
- (2018) Rudolf Korinthenberg DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- A Sequel to the Eteplirsen Saga: Eteplirsen Is Approved in the United States but Was Not Approved in Europe
- (2018) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Entering the Modern Era of Gene Therapy
- (2018) Xavier M. Anguela et al. Annual Review of Medicine
- New treatments for serious conditions: ethical implications
- (2017) N M P King et al. GENE THERAPY
- The Evolving Definition of the Term “Gene”
- (2017) Petter Portin et al. GENETICS
- Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
- (2017) Stephen Russell et al. LANCET
- FDA-Approved Oligonucleotide Therapies in 2017
- (2017) Cy A. Stein et al. MOLECULAR THERAPY
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Evolving Definition of the Term “Gene”
- (2017) Petter Portin et al. GENETICS
- Global Manufacturing of CAR T Cell Therapy
- (2017) Bruce L. Levine et al. Molecular Therapy-Methods & Clinical Development
- Gene Therapy for “Bubble Boy” Disease
- (2016) Jonathan Hoggatt CELL
- Talimogene Laherparepvec for the Treatment of Advanced Melanoma
- (2016) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
- (2016) William M Mitchell Expert Review of Clinical Pharmacology
- Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID
- (2016) Joshua Schimmer et al. Human Gene Therapy Clinical Development
- First Oncolytic Viral Therapy for Melanoma
- (2015) Cancer Discovery
- Progresses towards safe and efficient gene therapy vectors
- (2015) Sergiu Chira et al. Oncotarget
- Improved Antisense Oligonucleotide Design to Suppress Aberrant SMN2 Gene Transcript Processing: Towards a Treatment for Spinal Muscular Atrophy
- (2013) Chalermchai Mitrpant et al. PLoS One
- Europe gives gene therapy the green light
- (2012) Karl Gruber LANCET
- Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union
- (2012) Seppo Ylä-Herttuala MOLECULAR THERAPY
- Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
- (2010) David Escors et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Viral vectors: from virology to transgene expression
- (2008) D Bouard et al. BRITISH JOURNAL OF PHARMACOLOGY
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search